Park Ha Biological Technology Co., Ltd. Class A
As of Oct 22, 2026, Park Ha Biological Technology is in Stage 4, the downtrend phase, now in week 15 (since Jul 14, 2026). It closed at $2.36, 98.5% below its 52-week high and below its 200-day average, which is falling.
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is BYAH early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
BYAH among Household & Personal Products29th of 30 by relative strength
All 30 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | SKIN | Stage 2 · wk 2 | 99 | +1538.8% |
| 2 | ACU | Stage 2 · wk 17 | 92 | +2.5% |
| 3 | HELE | Stage 3 · wk 3 | 86 | −1.9% |
| 4 | EPC | Stage 2 · wk 17 | 86 | +6.7% |
| 5 | SPB | Stage 3 · wk 3 | 86 | −6.3% |
| 6 | KVUE | Stage 3 · wk 5 | 82 | +12.5% |
| 7 | HNST | Stage 2 · wk 22 | 80 | −6.2% |
| 8 | CL | Stage 3 · wk 6 | 74 | +14.0% |
| …29 | BYAH | Stage 4 · wk 15 | 3 | −10.6% |
Park Ha Biological Technology: quick answers
What stage is Park Ha Biological Technology in?
As of Oct 22, 2026, Park Ha Biological Technology (BYAH) is in Stage 4, the downtrend phase. It entered Stage 4 on Jul 14, 2026 and is in week 15. What the four stages mean
Is Park Ha Biological Technology in an uptrend?
No. Park Ha Biological Technology is in a Stage 4 downtrend. It trades 81.5% below its 200-day average, which is falling.
How far is Park Ha Biological Technology from its 52-week high?
Park Ha Biological Technology closed at $2.36 on Oct 22, 2026, 98.5% below its 52-week high of $154.00. Its 52-week low is $2.20.
How has Park Ha Biological Technology performed over the past year?
As of Oct 22, 2026, Park Ha Biological Technology is down 98.5% over the past year and down 96.5% so far in 2026.
Which sector and industry is Park Ha Biological Technology in?
Park Ha Biological Technology is in the Household & Personal Products industry, part of the Consumer Staples sector.
About this companyConsumer Staples· Household & Personal Products
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. It operates in two segments, Product Sales and Franchise Service. The company offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company has a strategic partnership with Star Plus Action (HK) Limited to build an AI-powered skincare and health ecosystem and expand its healthcare reach. Park Ha Biological Technology Co., Ltd. has strategic partnership with Cloud Factory Technology Holdings Limited to build ai-driven ecosystem for the beauty industry. The company was founded in 2016 and is headquartered in Wuxi, the People's Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.